Tech Company Financing Transactions
Rivia Funding Round
Rivia closed a $15 million Series A financing round on 3/18/2026. Investors included Earlybird Venture Capital, Amino Collective and Nina Capital.
Transaction Overview
Company Name
Announced On
3/18/2026
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand its teams in Zurich and Boston and to accelerate the rollout of its new suite of embedded AI agents.
Company Information
Company Status
Private & Independent
Industry
Infrastructure
Mailing Address
Technoparkstrasse 1
Zürich, 8005
Switzerland
Zürich, 8005
Switzerland
Phone
Undisclosed
Website
Email Address
Overview
We know the challenges of clinical trials firsthand because we've lived them. Our journey began while treating patients and working from our co-founder's apartment. Now, our commitment to revolutionizing drug development is stronger than ever. With deep technical and medical expertise, we're a growing team dedicated to transforming the lifecycle of clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Erik Scalfaro
Chief Medical Officer
Henk Streefkerk
Chief Technical Officer
Tiago Kieliger
Co-Founder
Pietro Scalfaro
Browse more venture capital transactions:
Prev: 3/18/2026: Rhonexum venture capital transaction
Next: 3/18/2026: Andromeda venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs